pharmacopeia

Acute Myeloid Leukaemia

also: Acute Myeloid Leukemia

26 drugs10,663 FAERS reportsMedDRA PT
GET
/api/v1/reaction/acute-myeloid-leukaemia
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

Drugs reporting Acute Myeloid Leukaemia (26)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Afamitresgene Autoleucel233%
  2. 2Gilteritinib3368.9%
  3. 3Azacitidine2,1657.5%
  4. 4Daunorubicin2727.4%
  5. 5Betibeglogene Autotemcel36.3%
  6. 6Decitabine2444.9%
  7. 7Mitoxantrone2964.8%
  8. 8Gemtuzumab Ozogamicin1474.1%
  9. 9Carmustine1723.8%
  10. 10Enasidenib1193.7%
  11. 11Ibritumomab Tiuxetan553.6%
  12. 12Idarubicin383.5%
  13. 13Chlorambucil1313.4%
  14. 14Dactinomycin713.3%
  15. 15Pentetreotide43.1%
  16. 16Venetoclax1,8033.0%
  17. 17Bleomycin3043.0%
  18. 18Floxuridine42.8%
  19. 19Dacarbazine1852.6%
  20. 20Quizartinib142.5%
  21. 21Cytarabine1,5212.5%
  22. 22Ifosfamide5092.4%
  23. 23Sodium Iodide242.1%
  24. 24Melphalan5082.1%
  25. 25Posaconazole3102.0%
  26. 26Etoposide1,4262.0%

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients